Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors-Reference-Cited by-同舟云学术

Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors

Published:2016-07-01 Issue:5 Volume:34 Page:596-603
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Mizugaki Hidenori,Yamamoto Noboru^ORCID,Murakami Haruyasu,Kenmotsu Hirotsugu,Fujiwara Yutaka,Ishida Yoshimasa,Kawakami Tomohisa,Takahashi Toshiaki

Funder

Chugai Pharmaceutical Co., LTD

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-016-0371-6.pdf

Reference21 articles.

1. Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39:1–10. doi: 10.1016/j.immuni.2013.07.012

2. Zou W, Chen L (2008) Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 8:467–477. doi: 10.1038/nri2326

3. Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8:793–800. doi: 10.1038/nm730

4. Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED (2006) Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res 66:3381–3385. doi: 10.1158/0008-5472.CAN-05-4303

5. Hino R, Kabashima K, Kato Y, Yagi H, Nakamura M, Honjo T, Okazaki T, Tokura Y (2010) Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma. Cancer 116:1757–1766. doi: 10.1002/cncr.24899

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical immunotherapy in pancreatic cancer;Cancer Immunology, Immunotherapy;2024-03-02

2. Immune checkpoint inhibitor myocarditis in thymic epithelial tumors: a case report and literature review;Translational Cancer Research;2024-02

3. PD-1 blockade combined with gemcitabine plus nab-paclitaxel is superior to chemotherapy alone in the management of unresectable stage III/IV pancreatic cancer: a retrospective real-world study;Frontiers in Oncology;2023-10-27

4. Systemic treatment for advanced pancreatic cancer;World Journal of Gastrointestinal Oncology;2023-10-15

5. Pancreatic adenocarcinoma — current trends in diagnosis and treatment;Oncology in Clinical Practice;2023-08-23